Moderna (MRNA) PT Raised to $131 at JPMorgan on Post 1Q Contracts
Tweet
Share
E-mail
Get Alerts MRNA Hot Sheet
Price: $142.19 --0%
Rating Summary:
8 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 21 | New: 51
Rating Summary:
8 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 21 | New: 51
Trade Now!
Join SI Premium – FREE
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
JPMorgan analyst Cory Kasimov raised the price target on Moderna (NASDAQ: MRNA) to $131.00 (from $127.00) while maintaining a Neutral rating to account for additional contracts in 2021 that were signed after 1Q earnings.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Progress Software (PRGS) PT Lowered to $53 at Oppenheimer
- CPIC (2601:HK) PT Raised to HK$26 at Jefferies
- China Life Insurance Co. Ltd. (2628:HK) (LFC) PT Raised to HK$15 at Jefferies
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
JPMorgan, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
